Do new cancer drugs offer good value for money? The perspectives of oncologists, health care policy makers, patients, and the general population
Tatiana Dilla,1 Luís Lizan,2 Silvia Paz,2 Pilar Garrido,3 Cristina Avendaño,4 Juan J Cruz-Hernández,5 Javier Espinosa,6 José A Sacristán1 1Medical Department, Lilly, Madrid, 2Outcomes’10, Jaime I University, Castellón, 3Med...
Main Authors: | Dilla T, Lizan L, Paz S, Garrido P, Avendaño C, Cruz-Hernández JJ, Espinosa J, Sacristán JA |
---|---|
Format: | Article |
Language: | English |
Published: |
Dove Medical Press
2015-12-01
|
Series: | Patient Preference and Adherence |
Subjects: | |
Online Access: | https://www.dovepress.com/do-new-cancer-drugs-offer-good-value-for-money-the-perspectives-of-onc-peer-reviewed-article-PPA |
Similar Items
-
Using economic evaluations in implementation science to increase transparency in costs and outcomes for organizational decision-makers
by: Lisa Saldana, et al.
Published: (2022-04-01) -
The role of market makers in the Euronext milling wheat contract
by: Martin ZIEGELBAECK, et al.
Published: (2014-04-01) -
Maker-Literacy
by: Stefan Meißner
Published: (2022-02-01) -
What makes a maker teacher? Examining key characteristics of two maker educators
by: Janette Hughes, et al.
Published: (2022-01-01) -
FrameMaker 7 : the complete reference /
by: O'keefe, Sarah S., et al.
Published: (2002)